Artificial intelligence (AI) is rapidly transforming biomedicine, including genomic medicine. This comment explores three myths and controversies involving AI in genomic medicine, including: how clinicians will use AI; whether AI’s impressive on-paper performance will translate to the real world; how patient preferences may or may not impact AI’s transformation of the field. Based on this discussion, the comment concludes with three recommendations for an AI-based future of genomic medicine.
Benjamin D. Solomon (Sat,) studied this question.